Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey

OBJECTIVES: Juvenile idiopathic arthritis is the most common rheumatic disease in childhood. Biologic agents have changed the course of juvenile idiopathic arthritis. However, there are concerns regarding the occurrence of serious adverse events in patients receiving biologic agents. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Balcı, Sibel, Demir, İlksen, Serbes, Mahir, Doğruel, Dilek, Altıntaş, Derya Ufuk, Ekinci, Rabia Miray Kışla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792537/
https://www.ncbi.nlm.nih.gov/pubmed/33456079
http://dx.doi.org/10.5114/reum.2020.102001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792537/
https://www.ncbi.nlm.nih.gov/pubmed/33456079
http://dx.doi.org/10.5114/reum.2020.102001

Ejemplares similares